Evidence map›Paper›PMID 32513244›Full record

ArticleGenome biology2020

Molecular mechanisms of coronary disease revealed using quantitative trait loci for TCF21 binding, chromatin accessibility, and chromosomal looping.

Quanyi Zhao, Michael Dacre, Trieu Nguyen, Milos Pjanic, Boxiang Liu, Dharini Iyer, Paul Cheng, Robert Wirka, Juyong Brian Kim, Hunter B Fraser and 1 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Circulation · 2022
    Article
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Quanyi ZhaoDivision of Cardiovascular Medicine and Cardiovascular Institute, Stanford University School of Medicine, 300 Pasteur Dr. Falk CVRC, Stanford, CA, 94305, USA.
Michael DacreDepartment of Biology, Stanford University, Stanford, CA, 94305, USA.
Trieu NguyenDivision of Cardiovascular Medicine and Cardiovascular Institute, Stanford University School of Medicine, 300 Pasteur Dr. Falk CVRC, Stanford, CA, 94305, USA.
Milos PjanicDivision of Cardiovascular Medicine and Cardiovascular Institute, Stanford University School of Medicine, 300 Pasteur Dr. Falk CVRC, Stanford, CA, 94305, USA.
Boxiang LiuDivision of Cardiovascular Medicine and Cardiovascular Institute, Stanford University School of Medicine, 300 Pasteur Dr. Falk CVRC, Stanford, CA, 94305, USA.
Dharini IyerDivision of Cardiovascular Medicine and Cardiovascular Institute, Stanford University School of Medicine, 300 Pasteur Dr. Falk CVRC, Stanford, CA, 94305, USA.
Paul ChengDivision of Cardiovascular Medicine and Cardiovascular Institute, Stanford University School of Medicine, 300 Pasteur Dr. Falk CVRC, Stanford, CA, 94305, USA.
Robert WirkaDivision of Cardiovascular Medicine and Cardiovascular Institute, Stanford University School of Medicine, 300 Pasteur Dr. Falk CVRC, Stanford, CA, 94305, USA.
Juyong Brian KimDivision of Cardiovascular Medicine and Cardiovascular Institute, Stanford University School of Medicine, 300 Pasteur Dr. Falk CVRC, Stanford, CA, 94305, USA.
Hunter B FraserDepartment of Biology, Stanford University, Stanford, CA, 94305, USA.
Thomas QuertermousDivision of Cardiovascular Medicine and Cardiovascular Institute, Stanford University School of Medicine, 300 Pasteur Dr. Falk CVRC, Stanford, CA, 94305, USA. tomq1@stanford.edu.ORCID 0000-0002-7645-9067
Cardiovascular Institute of the South · USStanford University · US

Funding

Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Seung K Kim · 2017 to 2026
$19.5M
Causal variant association mechanisms in TCF21 binding coronary disease lociR01HL134817 · NHLBI · STANFORD UNIVERSITY · PI THOMAS QUERTERMOUS · 2017 to 2026
$6.2M
Mechanism of the Coronary Heart Disease Association at Chromosome 6q23.2R01HL109512 · NHLBI · STANFORD UNIVERSITY · PI QUERTERMOUS, THOMAS · 2011 to 2019
$6.1M
The SMAD3 signaling network in coronary artery disease riskR01HL139478 · NHLBI · STANFORD UNIVERSITY · PI THOMAS QUERTERMOUS · 2018 to 2026
$3.7M
Molecular Mechanisms of Insulin Resistance Associated LociR01DK107437 · NIDDK · STANFORD UNIVERSITY · PI QUERTERMOUS, THOMAS · 2016 to 2019
$2.2M
Identification of causal coronary heart disease variation in smooth muscle cellsR33HL120757 · NHLBI · STANFORD UNIVERSITY · PI QUERTERMOUS, THOMAS · 2016 to 2018
$1.6M
The molecular mechanisms of SMAD3-mediated coronary disease riskF32HL143847 · NHLBI · STANFORD UNIVERSITY · PI CHENG, PAUL PO SHENG · 2018 to 2019
$114k
NCIRD CDC HHS H23 IP000999NHLBI NIH HHS F32 HL143847NHLBI NIH HHS R01 HL109512NHLBI NIH HHS R01 HL134817NHLBI NIH HHS R01 HL139478NHLBI NIH HHS R33 HL120757NIDDK NIH HHS P30 DK116074NIDDK NIH HHS R01 DK107437NIH HHS R01DK107437NIH HHS R01HL109512NIH HHS R01HL134817NIH HHS R01HL139478NIH HHS R33HL120757
6 · The paper itself

Abstract

backgroundTo investigate the epigenetic and transcriptional mechanisms of coronary artery disease (CAD) risk, as well as the functional regulation of chromatin structure and function, we create a catalog of genetic variants associated with three stages of transcriptional cis-regulation in primary human coronary artery vascular smooth muscle cells (HCASMCs).

resultsWe use a pooling approach with HCASMC lines to map regulatory variants that mediate binding of the CAD-associated transcription factor TCF21 with ChIPseq studies (bQTLs), variants that regulate chromatin accessibility with ATACseq studies (caQTLs), and chromosomal looping with Hi-C methods (clQTLs). We examine the overlap of these QTLs and their relationship to smooth muscle-specific genes and transcription factors. Further, we use multiple analyses to show that these QTLs are highly associated with CAD GWAS loci and correlate to lead SNPs where they show allelic effects. By utilizing genome editing, we verify that identified functional variants can regulate both chromatin accessibility and chromosomal looping, providing new insights into functional mechanisms regulating chromatin state and chromosomal structure. Finally, we directly link the disease-associated TGFB1-SMAD3 pathway to the CAD-associated FN1 gene through a response QTL that modulates both chromatin accessibility and chromosomal looping.

conclusionsTogether, these studies represent the most thorough mapping of multiple QTL types in a highly disease-relevant primary cultured cell type and provide novel insights into their functional overlap and mechanisms that underlie these genomic features and their relationship to disease risk.

Indexed as

Quantitative Trait LociBasic Helix-Loop-Helix ProteinsCoronary DiseaseCoronary VesselsEpigenesis, GeneticFibronectinsHumansMuscle, Smooth, VascularMyocytes, Smooth MusclePrimary Cell CultureSmad3 ProteinTransforming Growth Factor beta1Basic Helix-Loop-Helix ProteinsFibronectinsFN1 protein, humanSmad3 ProteinSMAD3 protein, humanTCF21 protein, humanTGFB1 protein, humanTransforming Growth Factor beta1Chromatin accessibilityChromosomal loopingCoronary artery diseaseQuantitative trait locusSmooth muscle cellsTCF21

Identifiers

PMID32513244
PMCPMC7278146
OpenAlexW3033773644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.